Skip to main content
Equibles
NTRA logo

NTRA · Natera, Inc. · Held by Funds

Track NTRA — free

Use NTRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NTRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$419.01 +5.70 (+1.38%)
Russell 1000 member Rebalance outlook locked
Market Cap
$59.47B
Shares
144.14M
Volume · Oct 1 502.72K Avg daily vol (3M) 1.38M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding NTRA

737 fund positions
Fund Balance Value % of Fund Open
JPMorgan Large Cap Growth Fund 5,550,940 $1,506,802,663 1.24%
VANGUARD TOTAL STOCK MARKET INDEX FUND 4,320,351 $1,172,759,279 0.05%
VANGUARD SMALL-CAP INDEX FUND 3,119,416 $846,765,473 0.45%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,799,359 $488,436,001 1.04%
VANGUARD EXTENDED MARKET INDEX FUND 1,642,271 $445,794,463 0.46%
Fidelity Contrafund 1,617,222 $438,994,912 0.24%
Franklin Dynatech Fund 1,450,000 $393,602,500 1.30%
MFS Mid Cap Growth Fund 1,345,572 $300,560,418 2.18%
iShares Biotechnology ETF 967,683 $262,677,550 2.89%
T. Rowe Price New Horizons Fund, Inc. 817,775 $221,985,024 1.51%
Growth Fund of America 988,724 $220,851,280 0.06%
iShares Russell Mid-Cap Growth ETF 805,893 $218,759,655 1.01%
T. Rowe Price Large-Cap Growth Fund 800,499 $217,295,454 1.06%
JPMorgan Mid Cap Growth Fund 781,556 $212,153,376 1.60%
JPMorgan Growth Advantage Fund 652,974 $177,249,792 0.79%
VANGUARD U.S. GROWTH FUND 783,620 $175,037,199 0.37%
T. Rowe Price Health Sciences Fund, Inc. 632,146 $171,596,032 1.44%
T. Rowe Price Mid-Cap Growth Fund, Inc. 595,467 $161,639,517 0.70%
Fidelity Extended Market Index Fund 712,868 $159,233,325 0.37%
iShares Russell Mid-Cap ETF 561,727 $152,480,794 0.27%
iShares Russell 1000 Growth ETF 521,495 $141,559,818 0.11%
Fidelity Mid Cap Index Fund 517,405 $138,540,363 0.27%
BlackRock Mid-Cap Growth Equity Portfolio 586,635 $131,036,660 2.33%
State Street(R) SPDR(R) S&P(R) Biotech ETF 459,937 $124,849,899 1.16%
Federated Hermes MDT Mid Cap Growth Fund 445,258 $119,222,282 1.81%
SMALLCAP World Fund Inc 396,421 $107,608,480 0.11%
First Trust NYSE Arca Biotechnology Index Fund 393,185 $106,730,068 3.79%
THE HARTFORD GROWTH OPPORTUNITIES FUND 397,574 $106,454,414 1.63%
JPMorgan Active Growth ETF 371,782 $100,920,224 1.01%
Lord Abbett Growth Leaders Fund 371,818 $99,557,988 1.34%
Heritage Fund 355,095 $95,080,237 1.79%
Fidelity Contrafund K6 344,293 $93,458,335 0.25%
Carillon Eagle Mid Cap Growth Fund 337,461 $91,603,788 1.75%
Federated Hermes Kaufmann Fund 335,000 $89,699,600 1.82%
VANGUARD HEALTH CARE INDEX FUND 394,919 $88,213,057 0.46%
ALGER FOCUS EQUITY FUND 327,884 $87,794,220 1.23%
Invesco Discovery Mid Cap Growth Fund 315,407 $84,453,378 1.25%
THE HARTFORD MIDCAP FUND 314,864 $84,307,985 2.63%
ERShares Private-Public Crossover ETF 297,907 $80,866,855 3.70%
ALGER SPECTRA FUND 294,154 $78,762,675 1.83%
Coatue Innovative Strategies Fund 289,764 $78,656,438 0.83%
Bridge Builder Large Cap Growth Fund 278,956 $75,722,606 0.25%
Select Biotechnology Portfolio 331,532 $74,054,303 1.41%
Select Health Care Portfolio 328,000 $73,265,360 1.27%
ARK Innovation ETF 257,162 $68,857,697 1.24%
SA Wellington Capital Appreciation Portfolio 248,459 $67,444,196 2.56%
Strategic Advisers U.S. Total Stock Fund 300,998 $67,233,923 0.07%
Schwab U.S. Large-Cap Growth ETF 295,371 $65,977,020 0.11%
VANGUARD EXPLORER FUND 242,967 $65,056,844 0.29%
ARK Genomic Revolution ETF 240,145 $64,301,225 4.13%
Showing 1–50 of 737 positions
Key facts CIK 1604821 CUSIP 632307104 13F (30d) 22 filings 16 filers Visit website Investor relations